Bicycle Therapeutics plc: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

Collaboration will leverage Bicycle Therapeutic's synthetic peptides for the discovery and development of multiple targeted radioconjugates of the company in oncology Advancing the use of

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Lisa Hennig ,David Borah ,Sarah Sutton ,Christian Rommel ,Kevin Lee ,Exchange Commission ,Pharmaceuticals Division ,Global Head Of Research ,Facebook ,Nasdaq ,Capital Markets Corporate Communications ,Member Of The Executive Committee ,Twitter ,Uk National Security ,Bicycle Therapeutic ,Bicycle Therapeutics ,Global Head ,Executive Committee ,Chief Executive Officer ,Investment Act ,Bicycle Toxin Conjugate ,Cancer Research United Kingdom Centre ,Private Securities Litigation Reform Act ,Annual Report ,Gefallene Big Techs ,Bicycle ,Herapeutics ,Player ,Winter ,Strategic ,Collaboration ,Development ,Novel ,Argeted ,Radionuclide ,Therapies ,Ncology ,